Internal Medicine Doctors in Manhattan, KS Accepting Medicare

27 Internal Medicine doctors found. Showing 21 - 27

Reggie J Voboril, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 College Ave, Suite E-110, Manhattan, KS 66502 Phone: 785-537-2651    Fax: 785-537-2975

Dr. Ramez Awni Smairat, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Research Dr, Manhattan, KS 66503 Phone: 785-539-4644    Fax: 785-539-8010

Dr. Glenn Thomas Reynolds, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Research Dr, Manhattan, KS 66503 Phone: 785-539-4644    Fax: 785-539-8010

Barbara Diane Taylor, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave, Suite C-143, Manhattan, KS 66502 Phone: 785-537-4940    Fax: 785-537-0836

Travis Koeneke, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 College Ave, Suite E-110, Manhattan, KS 66502 Phone: 785-537-2651    Fax: 785-537-4276

Dr. Scott A Coonrod, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Research Park Dr, Manhattan, KS 66502 Phone: 785-537-2651

Dr. Roger G Peck, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Research Park Dr, Manhattan, KS 66502 Phone: 785-537-2651

News Archive

Anti-inflammatory strategy could lead to improved survival of children with neuroblastoma

Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumor stroma reduces tumor growth in experimental neuroblastoma models.

Global research community revises WHO COVID-19 research priorities

Researchers have described the results of a survey aiming to determine the current applicability of the World Health Organization's COVID-19 Research Roadmap and whether there are new priorities that should be focused on at this point in time during the pandemic.

Bayer submits regorafenib NDA with FDA for treatment of metastatic and/or unresectable GIST

Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment.

Horizon's new products offer new feel-good snacking options for families

Horizon®, a leading national organic dairy brand, today announced the launch of a new line of snack products. Horizon Snack Crackers, Sandwich Crackers and Snack Grahams mark the brand's continued evolution outside of the dairy case, following the launch of several Mac & Cheese products in January.

UK Bioscientists create GM knowledge pipeline to help fight future food insecurity in African nations

UK Bioscientists are transferring GM knowledge and technology from the developed to the developing world to help fight future food insecurity in Sub-Saharan Africa.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)